2 completed, 2 terminated, 1 suspended. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 2, Terminated 2, Suspended 1 |
Follow Oxymorphone: new trials by email Literature Review of Oxymorphone trials Research Report on Oxymorphone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects Oxymorphone HCl, Placebo - Post-Operative Pain, Acute Pain | Phase 3 | Terminated | Endo USA Inc., a Keenova Therapeutics Company | 28 | 2016-04-01 | 2021-10-26 |
| Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children Oxymorphone hydrochloride (HCl) - Chronic Pain, Postsurgical Pain | Phase 3 | Suspended | Endo USA Inc., a Keenova Therapeutics Company | 15 | 2013-03-11 | 2020-12-23 |
| Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects oxymorphone HCl - Post Operative Pain | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 61 | 2010-12-13 | 2021-08-20 |
| Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects Oxymorphone ER - Chronic Pain | Phase 3 | Terminated | Endo USA Inc., a Keenova Therapeutics Company | 27 | 2008-11-17 | 2020-12-16 |
| Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain Oxymorphone immediate release - Acute Pain | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 320 | 2004-09-01 | 2024-01-02 |
Acute Pain (3) · Pain, Postoperative (3) · Chronic Pain (2) · Pain (1)
Endo USA Inc., a Keenova Therapeutics Company (5)
United States (5)
Saji Vijayan (1) · Saji Vijayan, MD (1) · Shannon Dalton (1)